Nootropic Peptides Research: What Does It Actually Study?
The term nootropic broadly refers to compounds studied for their interactions with cognitive function — memory, learning, focus, and neuroprotection. In a nootropic peptides research setting, these compounds are distinct from conventional pharmacological agents in one important respect: they tend to operate through highly targeted mechanisms, interacting with specific receptor systems or signalling pathways rather than producing broad, non-selective effects across the central nervous system.
This specificity is what makes them valuable laboratory tools. When a researcher wants to understand how brain-derived neurotrophic factor (BDNF) influences synaptic plasticity, or how GABAergic tone modulates anxiety-related behaviour in preclinical models, targeted compounds like Semax and Selank provide a level of mechanistic precision that blunt-instrument approaches cannot.
Semax: BDNF Upregulation and Neurotrophic Signalling Research
Semax is a synthetic heptapeptide analogue of adrenocorticotropic hormone (ACTH), specifically derived from the ACTH(4-7) sequence. Originally developed within Russian neuroscience research programmes, it has accumulated a meaningful body of preclinical literature over several decades.
Its primary mechanism of research interest is the upregulation of BDNF — a neurotrophin that plays a central role in synaptic plasticity, neuronal survival, and the formation of new neural connections. Research has also associated Semax with effects on dopaminergic and serotonergic pathways, both of which are implicated in mood regulation, learning, and memory consolidation.
In laboratory models, Semax has been studied for its potential interactions with:
- Neuroplasticity pathways — via BDNF and nerve growth factor (NGF) expression
- Dopaminergic signalling — relevant to motivation and cognitive performance research
- Neuroprotection — studied in models of ischaemic injury and oxidative stress
In nootropic peptides research, Semax remains one of the most studied compounds for its neurotrophic and neuroprotective properties.
For researchers investigating the neurotrophic signalling pathways that underpin learning and memory, Semax represents a well-characterised tool with a documented preclinical literature base.
Selank: GABAergic Modulation and Stress Pathway Research
Where Semax is generally characterised as the more pro-cognitive and neurotrophic compound, Selank occupies a distinct but complementary position in nootropic peptides research — primarily studied for its interactions with anxiolytic and stress-modulating pathways.
Selank is a synthetic neuropeptide derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its primary mechanisms of research interest involve modulation of the GABAergic system — specifically receptor activity and gene expression in neurotransmission pathways — alongside effects on enkephalinase activity and serotonin metabolism.
Research suggests Selank’s GABAergic interactions may be relevant to studying:
- Anxiety and stress response models — via HPA axis modulation
- Cognitive performance under stress conditions — studying how stress-induced suppression of hippocampal neurogenesis can be modulated
- Immune-cognitive interactions — given its tuftsin-derived structure and immunomodulatory properties
The combination of Semax and Selank has attracted particular research interest precisely because their mechanisms are complementary rather than redundant — Semax addresses neurotrophic signalling while Selank addresses stress-pathway suppression of neurogenesis. Together, they allow researchers to investigate whether additive or synergistic effects occur when both pathways are targeted simultaneously.
ReGen-X supplies Selank 10mg for laboratory research use.
NAD+: The Metabolic Foundation of Neuronal Health
Nicotinamide adenine dinucleotide — NAD+ — occupies a unique position in nootropic peptides research. Unlike Semax and Selank, which are peptides targeting specific neurological receptor pathways, NAD+ is a coenzyme that serves as a fundamental substrate for cellular energy metabolism, DNA repair, and cellular signalling across virtually every tissue in the body — including, critically, the brain.
NAD+ levels naturally decline with age, and this decline has become an increasingly active area of neuroscience research. The question researchers are investigating is a significant one: does the age-related decline in NAD+ contribute directly to the cognitive changes associated with ageing and neurodegeneration?
Recent research has produced compelling data in preclinical models. A systematic review published in PMC found evidence that NAD+ precursors improved both behavioural and neuroprotective outcomes in rodent models of cognitive impairment, including improvements in spatial memory and contextual learning.
Research published in Science Advances identified a specific mechanism — the NAD+-EVA1C splicing axis — through which NAD+ may protect against tau-related neuronal dysfunction, with improvements in memory performance demonstrated in animal models carrying tau mutations.
The mechanistic pathways being studied in relation to NAD+ and cognitive function include:
- Mitochondrial function — NAD+ is essential for mitochondrial energy production in neurons, and mitochondrial dysfunction is implicated in multiple neurodegenerative conditions
- Sirtuin activation — particularly SIRT1 and SIRT3, which regulate neuroinflammation and oxidative stress responses
- DNA repair — NAD+ is a substrate for PARP enzymes involved in DNA strand break repair, relevant to neuronal longevity research
- Neuroinflammation — research has demonstrated reductions in neuroinflammatory markers in preclinical models following NAD+ administration
For researchers studying the metabolic underpinnings of cognitive ageing, neurodegeneration, or neuronal resilience, NAD+ represents one of the most mechanistically rich compounds currently available for laboratory investigation.
Kisspeptin: Neurological Research Beyond the HPG Axis
Kisspeptin is perhaps the most multifaceted compound in this group. Best known in research for its role in regulating the hypothalamic-pituitary-gonadal (HPG) axis — where it acts as a key upstream regulator of gonadotropin-releasing hormone (GnRH) neuron activity — its role in nootropic peptides research extends into areas of neuroscience that are only beginning to be mapped.
Kisspeptin neurons are distributed not only in the hypothalamus but also in limbic system structures associated with emotional processing, reward, and social behaviour. This broader neurological distribution has opened nootropic peptides research questions about kisspeptin’s role beyond reproductive endocrinology — including its interactions with mood regulation pathways and stress response systems.
For researchers studying the HPG axis specifically, kisspeptin is an invaluable tool: it acts upstream of GnRH neurons, effectively probing the pulse generator of the reproductive hormonal cascade. Understanding where disruptions in this axis originate — at the kisspeptin level, the GnRH level, or downstream — requires compounds that can isolate each node independently.
Kisspeptin 10mg is available from ReGen-X for laboratory research use.
Why Nootropic Peptides Research Matters
The global burden of cognitive decline and neurodegenerative disease is significant — and growing. As populations age, the scientific urgency around understanding the mechanisms of neurodegeneration, neuroprotection, and cognitive resilience has never been greater.
Nootropic peptides research contributes to that understanding at a mechanistic level. By studying how compounds like Semax influence BDNF expression, how Selank modulates GABAergic tone under stress, how NAD+ supports mitochondrial function in ageing neurons, and how Kisspeptin regulates upstream hormonal signalling, researchers build a more complete picture of the neurobiological systems involved in cognitive health.
What makes nootropic peptides research particularly valuable is the specificity of the compounds involved. Unlike broad-spectrum pharmacological interventions, peptides allow researchers to isolate individual pathways and study their contribution to cognitive outcomes independently. This level of precision is essential for building reproducible, meaningful data in neuroscience.
South Africa’s research community is increasingly engaged with these questions — and nootropic peptides research is no longer confined to international institutions. Access to verified, research-grade compounds is the prerequisite for meaningful work in this space, and local supply is increasingly available for qualified laboratory researchers.
For a foundational understanding of the peptide class these compounds belong to, see our post What Are Peptides? A Beginner’s Guide. Browse the full ReGen-X research compound range — all products are independently third-party tested and supplied strictly for laboratory research use.
Important Research Use Notice
All compounds supplied by ReGen-X are intended strictly for laboratory and scientific research use only. They are not medicines, not supplements, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied. Researchers are responsible for ensuring compliance with all applicable SAHPRA regulations and institutional guidelines in their jurisdiction.